医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

MiraMed is Pleased to Announce its Global Subsidiary Ajuba Solutions Expands With a New 600-Seat Facility at Ambattur, Chennai, India

2015年02月19日 AM12:32
このエントリーをはてなブックマークに追加


 

JACKSON, Mich.

MiraMed Global Services, LLC, (MiraMed) is pleased to announce that its global subsidiary, Ajuba Solutions, a premier service provider of healthcare revenue cycle management (RCM) headquartered in Chennai, India has launched its new facility at the One IndiaBulls Park at Ambattur making it Ajuba’s fifth and the largest delivery center in Chennai, India. The 50,000 sq. ft. facility with a capacity to seat over 600 employees was inaugurated by Mr. John Flemming, Chief Commercial Officer, US Consulate, Chennai. Tony Mira, Founder and Group CEO, Ajuba Solutions, along with the Directors of Ajuba Solutions were present at the inauguration.

Ajuba also inaugurated its new corporate office that will house advanced recruitment and training centers apart from the company’s core administration at Tidel Park.

Speaking at the inaugural ceremony of the company’s new facility at Ambattur, Tony Mira said, “The continued growth of the healthcare industry in US has increased the amount of opportunities for Ajuba. Currently we have over 3,500 employees in Ajuba and the number could grow by about 20 percent by the end of 2015. I’m extremely confident that today Ajuba is well-positioned to meet the demands of all healthcare revenue cycle management opportunities with our experienced talent base. Our intent is to expand our employee base and stand tall as the leading global healthcare RCM & Analytics Company.”

The global healthcare provider outsourcing market is witnessing a major growth trend. 2015 is expected to grant tremendous opportunities for the healthcare outsourcing market and Ajuba, being a leading player in the industry, is definitely on a growth path.

About MiraMed

Headquartered in Jackson, Michigan, MiraMed Global Services stands as the premier global provider of business process outsourcing solutions to healthcare organizations nationwide. MiraMed partners with hospitals, health networks, physician practices and related industry service organizations to provide a broad portfolio of customizable solutions, uncover and capitalize on hidden financial opportunities, improve productivity and ultimately increase profits. MiraMed has offices in Chennai, India, Manila, Philippines, Chicago, Illinois, Portland, Oregon, Dallas, Texas and Thousand Oaks, California.

MiraMed pairs healthcare industry experts with world-class processes, infrastructure and technology to deliver meaningful and measurable results. This proprietary model enables sustainable change by delivering a complete, customizable end-to-end solution devised to meet a client’s own unique financial and organizational needs.

If you would like more information about this topic, please go to www.miramedgs.com or email info@miramedgs.com.

About Ajuba:

Ajuba Solutions is a premier provider of revenue cycle outsourcing services to healthcare systems, hospitals, physician practice groups, academic medical centers, medical equipment suppliers, and billing and receivables management companies in the US. The company partners with clients to provide a broad portfolio of customizable solutions, uncover and capitalize on hidden financial opportunities, improve productivity and ultimately increase their profits. Ajuba is part of the MiraMed Global Services group which is headquartered in Jackson Michigan, USA. For more information visit www.ajubanet.net.

CONTACT

MiraMed
Tony Mira, 517-787-7432
info@miramedgs.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Fresenius Medical Care’s International Campaign Recognizes Nurses at the Center of Healthcare
  • Dr. Reddy’s Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market
  • AHF: Ten Ways WHO Catastrophically Failed the World
  • NANOBIOTIX Partners With LianBio to Develop and Commercialize Potential First-in-Class Radioenhancer NBTXR3 Across Tumor Types and Therapeutic Combinations in China and Other Asian Markets
  • Nanobiotix与联拓生物宣布达成战略合作,将携手在中国和亚洲其他市场对潜在首创的放射增强剂NBTXR3进行开发和商业化,涵盖多个瘤种和不同联合治疗方案